Swedish Pharmaceuticals & Biotech Best Growth Stocks

Camurus

Market Cap: SEK 39.9b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Xbrane Biopharma

Market Cap: SEK 652.7m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Bonesupport Holding

Market Cap: SEK 19.0b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Devyser Diagnostics

Market Cap: SEK 2.3b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

BioGaia

Market Cap: SEK 10.9b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Moberg Pharma

Market Cap: SEK 400.0m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Vitrolife

Market Cap: SEK 17.5b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.